Matthaios Didagelos obtained his Medical Diploma and his PhD from the Medical School of the Aristotle University of Thessaloniki and completed his cardiology residency at the Skylitseio General Hospital of Chios and the AHEPA University Hospital of Thessaloniki. He is currently an Interventional Cardiologist at the 1st Cardiology Department of the AHEPA University Hospital, Thessaloniki, Greece. Prior to that, he was post-trained in Interventional Cardiology at the Golden Jubilee National Hospital, Glasgow, UK. He participates in national and international interventional cardiology and heart failure clinical trials and in EU translational studies about nanotechnology and valvular heart disease. He also serves as a reviewer for international scientific journals and is a member of the ESC and the EAPCI.